LabCorp to Sell Roche's AmpliPrep/COBAS TaqMan HIV-1 Dx | GenomeWeb
NEW YORK (GenomeWeb News) — Laboratory Corporation of America will be the first commercial laboratory in the US to sell Roche Diagnostics' AmpliPrep/COBAS TaqMan HIV-1 test, the company said today.
 
The US Food & Drug Administration approved the real-time PCR test May 11.
 
The product quantifies the amount of HIV virus in the blood to enable doctors to establish a baseline HIV infection level before starting treatment. They could also use the test to monitor patients' responses during treatment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.